# Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug

> **Open Intelligence Dossier** · First detected: 2026-07-27 22:07 UTC · Category: Business

## Executive Summary
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug" is generating significant coverage in the Business category, with 4 articles from 4 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Barchart.com, Morningstar, BioSpace and Dallas News. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Barchart.com | The $2.2 Billion Reason Forte BioSciences (FBRX) Stock Is Skyrocketing Today | [Source Link](https://news.google.com/rss/articles/CBMiuAFBVV95cUxPLVF1SHliRjVhRW1DMWVkd0JHS1JPTVlaMDVVUUY0bTgtalY4UGstdk9RRjJfWG9CbGlqZVYxbjJseEdNS1E2cGFPZk5nbkF2dXA3UDZEODh3SFd0c2hDeGFERUZMNktZZzZpQ2ZUa3FqcFdnd3JXd0U0a2lyWkpjZEhWOGQxcVg1UWtTajlsbmpDV3BjUDN6VlBENTJySG43eUVoTDlIek52Wmk3SFU0SS03X01PZjkw?oc=5) |
| Morningstar | Are FBRX, ACA, BGMS Obtaining Fair Deals for their Shareholders? | [Source Link](https://news.google.com/rss/articles/CBMivwFBVV95cUxQbDVQaTdKLW1lWmVnMEVzNnd6WFM3Mk5XMGdaWWZiZFBEc0ZNNm1WLUZJSzhJano1TnNUR3BoZUVLQVVvcVN3c0FBeGtnZVZUYUNrNW1zeUhwZFRERzctdXRJNy1rUFdSSW5QNnFtaC1yNDVXZll1eWNPLVVjanVsZGhERDVLeVdiT2VtR0lETnhDLWR6bWVkcS02MkIyejNuNmxoMktPejg0bzVfRk5jbUhteUJOZlh5bTVseDhCaw?oc=5) |
| BioSpace | Argenx deepens immuno expertise with $2.2B Forte Biosciences buy | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxQd3pndEVzX0lUN1BYWW9YMFNEcDlkWlRuYllZWDhKVkZ3WS1qWVVreTF4V0dTeG0xaXU2YXVWclRtb25tM3AxaUQtVlh0V1ZESFVWWGFzcWFIeU5rMmJucS1HTXE4aTVuSGc3c0owR3Rqb2FRWDFuRV9YYzBlajdnVi1XcjF4ZkxUdjZFemJhMGFfR0N4dE4xdXRB?oc=5) |
| Dallas News | Dallas biopharmaceutical company to be acquired for over $2B | [Source Link](https://news.google.com/rss/articles/CBMiuAFBVV95cUxPeDJtNUZ0OGROY1lxVnVNQzJENzhKTlZqZEt5Qlp1SU0wcjExclNIeDM5NnVvbmVKQVJCRHFRbTN5dzZrdFhJR2FNSkhZMVZPalNOX3I2aWVYRmlxWG5hdGlpdFdZUklNVUxRcGlXYkp6c1p5MmVSSnJybF9iRDJOcXJQaVUweTYzd2JFMkNPUXUxU01rZVN2TWNHWDFpbUk2STM1QXJ2blM2LXlQTmFyQkpEakZrVnhR?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-07-27/argenx-acquires-forte-for-2-2b-to-get-hands-on-phase-2-stage-vitiligo-drug*